For researchers in the medical field, measuring the impact of scientific contributions is often a critical factor in determining career progression, securing funding, and establishing overall value as a scientist. However, as practicing ophthalmologists and clinical investigators know all too well, the concept of “impact” can be elusive. Does a highly cited paper on a niche surgical technique have more value than a frequently downloaded review on dry eye disease?
The variability in how research metrics are applied raises significant concerns about how to accurately evaluate, compare, and differentiate true scientific influence. A recent scoping review by Waldman et al., published in Current Eye Research (2026), set out to clarify this landscape by characterizing the most frequently used metrics for evaluating research impact in ophthalmology.
Here is a comprehensive breakdown of how our field currently measures success, the hidden biases in our favorite metrics, and how we can move toward a fairer, more holistic evaluation of ophthalmic research.
The Current Landscape of Ophthalmic Research Metrics
To understand how impact is measured, researchers reviewed 1,100 studies published between 1955 and 2023 across major databases, ultimately including 77 relevant studies authored by ophthalmologists or affiliated with ophthalmology departments.
The findings revealed a heavy reliance on a small handful of traditional numbers. The review identified 17 distinct research metrics in use, but found that the vast majority (82%) were purely quantitative—meaning they rely strictly on numerical publication and citation data to calculate a score. Furthermore, the assessments were overwhelmingly applied at the article-level (26%) and the journal-level (23%), demonstrating that the field historically places the greatest value on the immediate reach and influence of a specific publication or the journal it lives in.
Interestingly, the quality of evidence investigating these metrics is generally low. The overwhelming majority of the included studies (94%) provided only Level 4 evidence, consisting largely of retrospective, cross-sectional, or bibliometric reviews rather than rigorous randomized interventions. This highlights a crucial need for more robust, longitudinal research into how we evaluate our own literature.
The “Big Four” Metrics: Strengths and Hidden Limitations
The scoping review revealed that four quantitative metrics dominate the evaluation of ophthalmic research, accounting for over 80% of all metric applications. While these tools are ubiquitous in academia, each carries significant limitations that ophthalmologists must be aware of when assessing a colleague’s or their own resume.
1. Citation Count (30% of use) Citation count is the most common metric used in our field. It operates on the simple assumption that if a paper is frequently cited by others, it is actively shaping future research or policy.
- The Reality: In ophthalmology, citation rates are heavily influenced by the author’s overall publication count, the journal’s impact factor, available funding, and whether the research originates from a high-income country.
- The Limitations: Citation counts can be artificially inflated by self-citation. Furthermore, they are surprisingly influenced by superficial factors such as journal accessibility (open vs. non-open access), the length of the title, the presence of hyphens or colons, and the size of the author’s social network. Studies also show that basic science articles and systematic reviews are naturally more likely to be highly cited, and there is a documented gender bias affecting citation rates. Crucially, standard citation counts do not account for the number of collaborators or author order.
2. Publication Count (22% of use) This metric simply tallies the volume of a researcher’s output, serving as an indicator of efficiency or yield.
- The Reality: On an individual level, publication count is heavily tied to academic rank and training; for instance, fellowship-trained ophthalmologists generally produce a significantly higher output than non-fellowship-trained peers.
- The Limitations: By itself, publication count is not a true measure of influence. It must always be compared alongside other metrics, like the H-index or citation count, to evaluate overall quality, and the total number of publications can frustratingly vary depending on which database is queried.
3. Journal Impact Factor (17% of use) The Journal Impact Factor (JIF) evaluates impact at the journal level rather than the individual article level, often serving as a proxy for prestige and quality. Ophthalmology journals tend to achieve higher JIFs if they publish a high volume of original clinical research, cover a wide variety of topics, and feature advance online publication.
- The Reality: Positive-result bias is real; ophthalmic studies reporting positive outcomes are more likely to be published in high-JIF journals. Conversely, highly specialized subspecialty journals often suffer from lower JIFs simply because they have smaller audience sizes and longer publishing turnaround times.
- The Limitations: JIF only considers citations over a narrow 2- or 5-year window. Its biggest flaw is that it is frequently misinterpreted as an indicator of the quality of a specific article within the journal, which it is not designed to measure. Furthermore, JIF does not account for collaborators, and evidence suggests a negative relationship between a journal’s impact factor and women authorship.
4. Hirsch Index (H-index) (14% of use) The H-index attempts to bridge the gap between quantity and quality, assuming that top-tier researchers produce both a high volume of work and highly impactful work.
- The Reality: Among US ophthalmologists, a higher H-index is positively correlated with advanced academic rank.
- The Limitations: The H-index heavily favors older, established researchers, as it is influenced by publication rate and researcher age. It is notoriously poor for comparing researchers across different scientific disciplines and fails to appropriately control for co-authorship. For example, early-stage researchers or those in slowly maturing sub-fields are distinctly disadvantaged by this metric.
The Rise of Mixed Metrics and Altmetrics
While purely quantitative numbers dominate, there is a growing recognition of “mixed metrics,” which utilize both quantitative and qualitative data. The most prominent of these is the Altmetric Attention Score, which tracks how much attention an article receives across news outlets, social media platforms, and public policy documents.
Altmetrics offer a diverse measure of a study’s visibility and its broader relevance to the public, moving beyond traditional academic circles. In the ophthalmic literature, researchers aiming to influence public policy frequently use social media to extend their reach, which is accurately captured by these scores. Interestingly, geographical trends show that Altmetrics are highly utilized in Turkish ophthalmic literature, reflecting specific nationwide efforts to increase public engagement with research.
However, Altmetrics are not without flaws. Digital sharing might boost a score, but it does not guarantee research quality, and scores can be artificially inflated by bots or reposted press releases. Furthermore, their reliability varies by geography; for instance, Twitter (X) is widely used in North America and Europe, which may bias Altmetric scores toward Western contexts and English-language content, underrepresenting the influence of research in regions where other platforms dominate.
The Role of Artificial Intelligence
As digital information retrieval evolves, artificial intelligence (AI) is beginning to shape how research metrics are defined and utilized. Tools like Semantic Scholar use AI to recommend relevant articles and classify certain references as “Highly Influential Citations”—citations that substantially influence the citing work. Moving forward, search engines driven by AI will likely heavily influence which ophthalmic papers are cited and how those citations are ultimately analyzed.
Leveling the Playing Field: Solutions and Future Directions
The current reliance on raw quantitative metrics often fails to capture the collaborative nature of modern ophthalmic research. When multi-center clinical trials involve dozens of authors, how do we assign credit fairly?
Researchers propose implementing weighted composite metrics to provide a more equitable assessment. Some practical solutions include:
- Fractional Counting: Each author receives an equal fraction (1/n) of the credit for a paper.
- Descending Weights: Assigning specific weights based on author position (e.g., 0.4 for the first author, 0.3 for the last/corresponding author, and 0.3 divided among the remaining co-authors) to reflect leadership roles.
- Adjusted Indices: Utilizing tools like the “hm-index,” which specifically adjusts a researcher’s H-index to account for multi-authored manuscripts.
Beyond mathematics, there is a global push to redefine what makes research valuable. Major initiatives like the San Francisco Declaration on Research Assessment (DORA), the Leiden Manifesto, and the Hong Kong Principles strongly caution against an over-reliance on single quantitative metrics.
These initiatives advocate for incorporating qualitative metrics—narrative approaches that describe research influence. While harder to measure, true impact in ophthalmology should recognize unquantifiable characteristics such as a researcher’s contributions to professional societies, their ability to mentor and teach the next generation of surgeons, and their success in fostering multi-disciplinary collaboration.
Furthermore, the UK’s Research Excellence Framework suggests broadening the definition of impact entirely, defining it as any benefit to the economy, society, culture, public policy, health, or quality of life that extends beyond academia. By adopting this wider lens, ophthalmologists could better recognize research that directly improves patient lives or streamlines healthcare economics, even if it doesn’t garner thousands of academic citations.
Conclusion and Takeaways for Ophthalmologists
Currently, the impact of ophthalmic research is judged almost exclusively through quantitative numbers like Citation Counts, Publication Counts, Impact Factors, and H-indices. While these tools are convenient, they are inherently biased and provide an incomplete picture of a researcher’s true value.
To evaluate impact more fairly, the ophthalmic community must evolve. Researchers should track both traditional measures and newer ones, like Altmetrics or author contribution scores, to present a comprehensive portfolio of their work. Academic departments and funding bodies must contextualize these metrics by discipline and adjust them for a clinician’s career stage. Finally, journal editors can drive transparency by displaying article-level metrics, requiring clear author contribution statements, and adopting inclusive guidelines like DORA.
By blending the quantitative with the qualitative, ophthalmology can move toward a more balanced, accurate, and meaningful way of judging the research that shapes the future of eye care.
Reference: Waldman, O. V., Gillette, J. S., Lin, J. C., Qureshi, R., Scott, I. U., & Greenberg, P. B. (2026). Characterizing Research Impact in Ophthalmology: A Scoping Review. Current Eye Research, 51(7), 847–856.
